Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

MONITOR-HF is the third randomized, controlled trial globally to show a significant health benefit for indicated heart failure patients
News | Heart Failure
European Study Finds the Abbott Cardiomems Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations

May 25, 2023 — New data presented from an investigator-sponsored European trial found managing indicated1 heart failure ...

Home May 26, 2023
Home
Emile Daoud, MD, helped develop a new surgical device at The Ohio State University Wexner Medical Center to prevent a common and serious complication during heart ablation procedures. The device gently moves the nearby esophagus away from the heart to prevent the ablation energy from causing damage.
News | Atrial Fibrillation
New Device Helps Prevent Complication During Common Heart Procedure

May 26, 2023 — Atrial fibrillation, or AFib , is the most common heart rhythm problem, affecting millions of Americans ...

Home May 26, 2023
Home
Additional real-world outcomes further demonstrate safety, efficacy and procedural reproducibility of the FARAPULSE Pulsed Field Ablation System
News | Left Atrial Appendage (LAA) Occluders
Data at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies

May 25, 2023 — Boston Scientific Corporation announced data supporting use of the company's key electrophysiology and ...

Home May 25, 2023
Home
Abbott's AVEIR DR i2i IDE study is the industry's first prospective study on the safety and performance of the world's first dual-chamber leadless pacemaker
News | Pacemakers
Abbott Unveils Late-breaking Data Showing the World's First Dual-chamber Leadless Pacemaker Study Met All Three Primary Endpoints

May 25, 2023 — Abbott announced late-breaking results from the AVEIR dual-chamber (DR) i2i Investigational Device ...

Home May 25, 2023
Home
Six-month outcomes from the FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) registry were presented on May 19 as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions.
News | SCAI
FLASH Study Finds Mechanical Thrombectomy Significantly Improves Patient Outcomes and Quality of Life Following a Pulmonary Embolism

May 24, 2023 — The largest interventional study focused on pulmonary embolisms highlighted importance of rapid removal ...

Home May 24, 2023
Home
The system treats severe pulmonary regurgitation (PR) in the native or surgically repaired right ventricular outflow tract (RVOT).
News | Structural Heart
Medtronic Harmony Transcatheter Pulmonary Valve Demonstrates Strong 2-year Outcomes

May 24, 2023 — Medtronic announced two-year results of their Harmony Transcatheter Pulmonary Valve (TPV) System, which ...

Home May 24, 2023
Home
PARAGLIDE-HF trial presented in a late breaking science session today at Heart Failure 2023
News | Heart Failure
Sacubitril/Valsartan Shows Benefit in Heart Failure with Ejection Fraction Above 40%

May 23, 2023 — Sacubitril/valsartan leads to greater reduction in plasma NT-proBNP levels compared to valsartan alone ...

Home May 23, 2023
Home
Greater Glasgow and Clyde Population Analysis presented in a late breaking science session today at Heart Failure 2023
News | Heart Failure
The Diagnosis of Heart Failure is More Often Missed than Made Especially for Women

May 23, 2023 — The diagnosis of  heart failure is usually missed, denying patients treatments that could improve ...

Home May 23, 2023
Home
MONITOR-HF trial presented in a late breaking science session at Heart Failure 2023
News | Heart Failure
Remote Monitoring Reduces Heart Failure Hospitalizations and Improves Quality of Life

May 23, 2023 — The first investigator-initiated study of remote pulmonary artery pressure monitoring has found that it ...

Home May 23, 2023
Home
Findings from two new studies highlight the success of left bundle branch area pacing (LBBAP), or his-bundle pacing (HBP) as an alternative to biventricular pacing (BVP) for patients requiring cardiac resynchronization therapy (CRT).
News | Cardiac Resynchronization Therapy Devices (CRT)
New Clinical Trials Demonstrate Benefits of Left Bundle Branch Area Pacing Compared to Standard Biventricular Pacing

May 22, 2023 — Findings from two new studies highlight the success of left bundle branch area pacing (LBBAP), or his ...

Home May 22, 2023
Home
Results from a pivotal clinical trial found a leadless pacemaker can deliver cardiac resynchronization therapy (CRT) among patients who were not able to be treated with conventional CRT and epicardial leads.
News | Cardiac Resynchronization Therapy Devices (CRT)
The WiSE CRT System Offers an Endocardial Alternative to Conventional CRT

May 22, 2023 — Results from a pivotal clinical trial found a leadless pacemaker can deliver cardiac resynchronization ...

Home May 22, 2023
Home
Figure 1. Results from the PROTECT II RCT, PROTECT III and RESTORE-EF Pooled Data Analysis
News | Intra-Aortic Balloon Pumps (IABP)
Analysis Showcases Potential for More Complete Revascularizations with Impella Compared to IABP during HRPCI

May 19, 2023 — Abiomed, part of Johnson & Johnson MedTech[1], announces results of a third-party analysis showing that ...

Home May 19, 2023
Home
Data presented at EuroPCR 2023 build on prior study results demonstrating TriClip is a safe and effective therapy to treat leaky tricuspid valves
News | Structural Heart
New Late-breaking Data Reinforce the Benefits of Abbott's TriClip Device for People with Tricuspid Valve Disease

May 19, 2023 — Abbott announced late-breaking data that add to the body of clinical evidence supporting the benefits of ...

Home May 19, 2023
Home
The first of Vektor Medical's new studies, being presented at HRS 2023, showcases vMap’s utility in unstable ventricular tachycardia (VT) ablation. (Graphic: Business Wire)
News | Atrial Fibrillation
Vektor Medical Releases Compelling Results for vMap Utility

May 18, 2023 — Vektor Medical, pioneers of technology to accurately map arrhythmias using only 12-lead ECG data ...

Home May 18, 2023
Home
Late-breaking clinical data presented at EuroPCR 2023 in Paris demonstrated Elixir Medical’s DynamX Bioadaptor restores vessel motion and function with better effectiveness at 12 months compared to a leading drug-eluting stent (DES).
News | EuroPCR
EuroPCR Late-Breaking Clinical Trial Data Finds Effectiveness of Elixir Medical’s DynamX Bioadaptor for PCI Treatment

May 17, 2023 — Elixir Medical has reported that important data were presented at a late-breaking clinical session during ...

Home May 17, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now